CSVAX | VIHAX | CSVAX / VIHAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 22 years | 9 years | - |
Gain YTD | 3.648 | 5.296 | 69% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 3000 | 67% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 531M | 8.38B | 6% |
Annual Yield % from dividends | 2.21 | 4.87 | 45% |
Returns for 1 year | 9.44 | 11.72 | 81% |
Returns for 3 years | -2.67 | 6.35 | -42% |
Returns for 5 years | 13.84 | 17.95 | 77% |
Returns for 10 years | 7.21 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MMIUX | 11.21 | -0.06 | -0.53% |
MassMutual Select TRP Intl Equity I | |||
FSAAX | 15.93 | -0.12 | -0.75% |
Fidelity Advisor Asset Manager 60% A | |||
NSMRX | 37.87 | -0.35 | -0.92% |
Nuveen Small/Mid-Cap Value I | |||
GRLLX | 19.23 | -0.29 | -1.49% |
Goldman Sachs Enh Core EqFund-ClassR | |||
RGABX | 71.73 | -1.21 | -1.66% |
American Funds Growth Fund of Amer R2 |